We are live on ! Find out more
RVPH

REVIVA PHARMA HLDGS INC
RVPH

Delisted

RVPH was delisted on the 13th of May, 2026.

Back to rankings

20 hedge funds and large institutions have $34.4M invested in REVIVA PHARMA HLDGS INC in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

81% more capital invested

Capital invested by funds: $19M → $34.4M (+$15.4M)

54% more funds holding

Funds holding: 13 → 20 (+7)

0.89% more ownership

Funds ownership: 1.17% → 2.06% (+0.89%)

Holders
20
Holders Change
+7
Holders Change %
+53.85%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KIM
Karpus Investment Management
New York
+$3.55M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$3.23M
3
GCIA
Gabelli & Co Investment Advisers
New York
+$1.95M
4
Walleye Trading
Walleye Trading
New York
+$1.88M
5
MSU
Mizuho Securities USA
New York
+$1.33M

Top Sellers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
-$491K
Name Holding Trade Value Shares
Change 		Change in
Stake
MSU
1
Mizuho Securities USA
New York
$4.49M +$1.33M +6,630 +42%
OAM
2
Oxford Asset Management
United Kingdom
$3.74M – – –
KIM
3
Karpus Investment Management
New York
$3.58M +$3.55M +17,701 New
WAM
4
Weiss Asset Management
Massachusetts
$3.34M +$1.27M +6,345 +62%
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$3.24M +$3.23M +16,100 New
PC
6
Periscope Capital
Ontario, Canada
$2.43M – – –
SCM
7
Shaolin Capital Management
Florida
$2.43M +$2.42M +12,075 New
GCIA
8
Gabelli & Co Investment Advisers
New York
$1.96M +$1.95M +9,725 New
Walleye Trading
9
Walleye Trading
New York
$1.89M +$1.88M +9,359 New
Goldman Sachs
10
Goldman Sachs
New York
$1.51M – – –
GF
11
Gabelli Funds
New York
$1.19M +$1.18M +5,910 New
PAM
12
Panagora Asset Management
Massachusetts
$1.17M – – –
KPF
13
K2 Principal Fund
Ontario, Canada
$755K +$752K +3,750 New
HIM
14
HGC Investment Management
Ontario, Canada
$670K – – –
BI
15
Bulldog Investors
New Jersey
$547K – – –
BCM
16
Basso Capital Management
Connecticut
$507K – – –
PAMP
17
Polar Asset Management Partners
Ontario, Canada
$504K – – –
CI
18
Cowen Inc
New York
$342K +$89.2K +445 +35%
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$90K +$89.2K +445 New
UBS Group
20
UBS Group
Switzerland
$11K +$11K +55 New
GCL
21
Glazer Capital LLC
New York
– -$491K -2,500 Closed

RVPH Hedge Fund Activity: Q1 2019 in Review

20 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q1 2019, worth a combined $34.4M — up 81% from $19M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new RVPH positions and 1 closed out — a net gain of 8 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Karpus Investment Management, opening a new position worth an estimated $3.55M. The largest seller was Glazer Capital LLC, exiting entirely with an estimated $491K sold.

  • 20 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q1 2019, up from 13 in Q4 2018.
  • Funds reported $34.4M of REVIVA PHARMA HLDGS INC stock for Q1 2019, up 81% quarter-over-quarter.
  • 9 funds opened new REVIVA PHARMA HLDGS INC positions in Q1 2019 and 1 closed out, a net change of +8 holders.
  • The largest REVIVA PHARMA HLDGS INC buyer in Q1 2019 was Karpus Investment Management, an estimated $3.55M added.
  • The largest REVIVA PHARMA HLDGS INC seller in Q1 2019 was Glazer Capital LLC, an estimated $491K sold.

Based on aggregated 13F filings for Q1 2019.